Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026)

Zimmer Biomet Holdings has reported Change in Accured Expenses for 18 years, with the latest figure at -$183.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 402.75% year-over-year to -$183.0 million; the trailing twelve-month figure through Mar 2026 stood at -$44.8 million (up 81.26% YoY), and the FY2025 full-year result was $101.8 million, up 131.61% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$183.0 million, down from $112.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $164.2 million in Q4 2023, with the low at -$183.0 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$20.9 million, with a median of -$34.3 million recorded in 2023.
• Year-over-year, Change in Accured Expenses slumped 477.36% in 2023 and surged 223.67% in 2025.
• Tracing ZBH's Change in Accured Expenses over 5 years: stood at $104.6 million in 2022, then jumped by 56.98% to $164.2 million in 2023, then sank by 171.44% to -$117.3 million in 2024, then surged by 196.25% to $112.9 million in 2025, then sank by 262.09% to -$183.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$183.0 million (Q1 2026), $112.9 million (Q4 2025), and -$51.5 million (Q3 2025), per Business Quant data.

Peer Comparison